CymaBay Alters NASH Hypothesis After Phase IIb Failure In Hepatic Fat Reduction

 
• By Joseph Haas
  
Many arrows missed hitting target mark. Shot miss. Multiple failed inaccurate attempts to hit archery target. Business challenge failure metaphor. Flat cartoon isolated vector object illustration
CymaBay missed a 12-week hepatic fat reduction endpoint in its Phase IIb study
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas